Beam Therapeutics Inc. (BEAM:NASDAQ) closed at $24.05 on October 23, 2026, down 2.08% on the day. The stock trades 37.1% below its 52-week high of $38.26 and 18.9% above its 52-week low of $20.23. Over the past year, it lost 14.0%. Beam Therapeutics Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, BEAM closed higher on 117 days (46%). Its best day was January 12, 2026 (+22.29%) and its worst was June 5, 2026 (-10.48%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 2 times.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises of Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Find more stocks like BEAM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.